Antiviral activity of Ellagic acid and Annona Muricata in cervical HPV related pre-neoplastic lesions: A randomized trial

Journal of Functional Foods

Volumn 35, Issue , 2017, Pages 549-554

  Le Donne, Maria ^a   Lentini, Maria ^a   Alibrandi, Angela ^a   Salimbeni, Vincenzino ^a   Giuffre, Giuseppe ^a   Mazzeo, Francesca ^a   Triolo, Onofrio ^a   D'Anna, Rosario ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Annona muricata; Ellagic acid; Human papilloma virus; Ki 67; Oncoproteins; Squamous intraepithelial lesion

Indexed keywords

EID: 85020936535     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2017.06.006     Document Type: Article

References (37)

1. Baseman, J.G., Koutsky, L.A., The epidemiology of human papillomavirus infections. Journal of Clinical Virology 32:Suppl 1 (2005), S16–S24.
2. Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., El Ghissassi, F.,. Cogliano, V., A review of human carcinogens – Part B: Biological agents. Lancet Oncology 10:4 (2009), 321–322.
3. Caldwell, M.E., De Nicola, G.M., Martins, C.P., Jacobetz, M.A., Maitra, A., Hruban, R.H., Tuveson, D.A., Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer. Oncogene 31 (2012), 1599–1608.
4. Crosignani, P., De Stefani, A., Fara, G.M., Isidori, A.M., Lenzi, A., Liverani, C.A.,. Zuccotti, G.V., Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health, 13, 2013, 642, 10.1186/1471-2458-13-642.
5. Darragh, T.M., Colgan, T., Cox, J.T., Heller, D.S., Henry, M.R., Luff, R.D.,. Wilbur, D.C., The lower anogenital squamous terminology standardization project for HPV-associated lesions: Background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Journal of Lower Genital Tract Disease 16 (2012), 205–242.
6. Di Domenico, F., Foppoli, C., Coccia, R., Perluigi, M., Antioxidants in cervical cancer: Chemopreventive and chemotherapeutic effects of polyphenols. Biochimica et Biophysica Acta 1822 (2012), 737–747.
7. Fantini, M., Benvenuto, M., Masuelli, L., Frajese, G.V., Tresoldi, I., Modesti, A., Bei, R., In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: Perspectives on cancer treatment. International Journal of Molecular Sciences 2015:16 (2015), 9236–9282.
8. Franceschi, S., Herrero, R., Clifford, G., Snijders, P.J., Arslan, A., Anh, P.T.,. Muñoz, N., Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. International Journal of Cancer 119 (2006), 2677–2684.
9. Giuffrè, G., Simone, A., Todaro, P., Le Donne, M., Caruso, C., Pizzo, A., Granese, D., Detection and genotyping of human papillomavirus in gynaecologic outpatients of Messina, eastern Sicily, Italy. Oncology Reports 23 (2010), 745–750.
10. Han, D.H., Lee, M.J., Kim, J.H., Antioxidant and apoptosis-inducing activities of ellagic acid. Anticancer Research 26 (2006), 3601–3606.
11. Insinga, R.P., Dasbach, E.J., Elbasha, E.H., Liaw, K.L., Barr, E., Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: An evaluation from multiple analytic perspectives. Cancer Epidemiology, Biomarkers & Prevention 16 (2007), 709–715.
12. Ismail, T., Calcabrini, C., Diaz, A.R., Fimognari, C., Turrini, E., Catanzaro, E.,. Sestili, P., Ellagitannins in cancer chemoprevention and therapy. Toxins, 8(5), 2016 pii: E151. doi: 10.3390/toxins8050151. Review.
13. Keating, J.T., Cviko, A., Riethdorf, S., Riethdorf, L., Quade, B.J., Sun, D.,. Crum, C.P., Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. American Journal of Surgical Pathology 25:7 (2001), 884–891.
14. Kim, G.S., Zeng, L., Alali, F., Rogers, L.L., Wu, F.E., Sastrodihardjo, S., McLaughlin, J.L., Muricoreacin and murihexocin C, mono-tetrahydrofuran acetogenins, from the leaves of Annona muricata. Phytochemistry 49 (1998), 565–571.
15. Kumar, D., Basu, S., Parija, L., Rout, D., Manna, S., Dandapat, J., Debata, P.R., Curcumin and Ellagic acid synergistically induce ROS generation, DNA damage, p53 accumulation and apoptosis in HeLa cervical carcinoma cells. Biomedicine & Pharmacotherapy 81 (2016), 31–37.
16. Le Donne, M., Giuffrè, G., Caruso, C., Nicotina, P.A., Alibrandi, A., Scalisi, R.,. Triolo, O., Human papillomavirus types distribution in eastern Sicilian females with cervical lesions. A correlation with colposcopic and histological findings. Pathology & Oncology Research 19:3 (2013), 481–487.
17. Levine, A.J., P53, the cellular gatekeeper for growth and division. Cell 88:3 (1997), 323–331.
18. Li, T.M., Chen, G.W., Su, C.C., Lin, J.G., Yeh, C.C., Cheng, K.C., Chung, J.G., Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Research 25:2A (2005), 971–979.
19. Martens, J.E., Arends, J., Van der Linden, P.J., De Boer, B.A., Helmerhorst, T.J., Cytokeratin 17 and p63 are Markers of the HPV Target Cell, the Cervical Stem Cell. Anticancer Research 24:2B (2004), 771–776.
20. Masumoto, N., Fujii, T., Ishikawa, M., Saito, M., Iwata, T., Fukuchi, T.,. Nozawa, S., P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Human Pathology 34:8 (2003), 778–783.
21. Moghadamtousi, S.Z., Kadir, H.A., Paydar, M., Rouhollahi, E., Karimian, H., Annona muricata leaves induced apoptosis in A549 cells through mitochondrial-mediated pathway and involvement of NF-κB. BMC Complementary and Alternative Medicine, 14, 2014, 299, 10.1186/1472-6882-14-299.
22. Moktar, A., Ravoori, S., Vadhanam, M.V., Gairola, C.G., Gupta, R.C., Cigarette smoke-induced DNA damage and repair detected by the comet assay in HPV-transformed cervical cells. International Journal of Oncology 35:6 (2009), 1297–1304.
23. Motoyama, S., Ladines-Llave, C.A., Luis, Villanueva S., Maruo, T., The role of human papilloma virus in the molecular biology of cervical carcinogenesis. Kobe Journal of Medical Sciences 50:1–2 (2004), 9–19.
24. Narayanan, B.A., Geoffroy, O., Willingham, M.C., Re, G.G., Nixon, D.W., P53/p21 (WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Letters 136:2 (1999), 215–221.
25. Ostor, A.G., Natural history of cervical intraepithelial neoplasia: A critical review. International Journal of Gynecological Pathology 12:2 (1993), 186–192.
26. Pieme, C.A., Kumar, S.G., Dongmo, M.S., Moukette, B.M., Boyoum, F.F., Ngogang, J.Y., Saxena, A.K., Antiproliferative activity and induction of apoptosis by Annona muricata (Annonaceae) extract on human cancer cells. BMC Complementary and Alternative Medicine, 14, 2014, 516, 10.1186/1472-6882-14-516.
27. Pinto, A.P., Schlecht, N.F., Woo, T.Y.C., Crum, C.P., Cibas, E.S., Biomarker (ProExTM C, p16INK4A, and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics. Modern Pathology 21:9 (2008), 1067–1074.
28. Plummer, M., Schiffman, M., Castle, P.E., Maucort-Boulch, D., Wheeler, C.M., A 2- year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. Journal of Infectious Diseases 195:11 (2007), 1582–1589.
29. Shi, J., Liu, H., Wilkerson, M., Huang, Y., Meschter, S., Dupree, W.,. Lin, F., Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProE(X) C, and p16INK4a/ ProE(X) C in cervical squamous intraepithelial lesions. Human Pathology 38:9 (2007), 1335–1344.
30. Skinner, S.R., Wheeler, C.M., Romanowski, B., Castellsagué, X., Lazcano-Ponce, E., Del Rosario-Raymundo, M.R.,. Baril, L., Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study. International Journal of Cancer 138:10 (2016), 2428–2438.
31. Syrjanen, K.J., Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV). European Journal of Obstetrics, Gynecology, and Reproductive Biology 65:1 (1996), 45–53.
32. Vogelstein, B., Lane, D., Levine, A.J., Surfing the p53 network. Nature 408:6810 (2000), 307–310.
33. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M.D., Dötsch, V.,. McKeon, F., P63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Molecular Cell 2:3 (1998), 305–316.
34. Zeng, L., Wu, F.E., Oberlies, N.H., McLaughlin, J.L., Sastrodihadjo, S., Five new monotetrahydrofuran ring acetogenins from the leaves of Annona muricata. Journal of Natural Products 59:11 (1996), 1035–1042.
35. Zhang, Y., Guo, L., Xing, P., Chen, Y., Li, F., Zhu, W., Lu, X., Increased expression of oncogene-induced senescence markers during cervical squamous cell cancer development. International Journal of Clinical and Experimental Pathology 7:12 (2014), 8911–8916.
36. Zhou, Y., Zheng, J., Li, Y., Xu, D.P., Li, S., Chen, Y.M., Li, H.B., Natural polyphenols for prevention and treatment of cancer. Nutrients, 8(8), 2016, 515, 10.3390/nu8080515.
37. Zou, C., Liu, H., Feugang, J.M., Hao, Z., Chow, H.H., Garcia, F., Green tea compound in chemoprevention of cervical cancer. Journal of the International Gynecological Cancer 20:4 (2010), 617–624.